{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:54:35Z","timestamp":1789786475719,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS090390"],"award-info":[{"award-number":["R01 NS090390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99 NS073936"],"award-info":[{"award-number":["K99 NS073936"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS038712"],"award-info":[{"award-number":["R01 NS038712"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG034228"],"award-info":[{"award-number":["R01 AG034228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["GRFP 2013137284"],"award-info":[{"award-number":["GRFP 2013137284"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.nbd.2017.10.002","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T05:00:20Z","timestamp":1507006820000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"PA","title":["The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin"],"prefix":"10.1016","volume":"109","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8554-065X","authenticated-orcid":false,"given":"Li","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"Merillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ochaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami J.","family":"Barmada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.10.002_bb0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.10.002_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnmol.2014.00063","article-title":"Ubiquitin pathways in neurodegenerative disease","volume":"7","author":"Atkin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0306-4522(95)00595-1","article-title":"Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study","volume":"72","author":"Augood","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2017.10.002_bb0020","doi-asserted-by":"crossref","first-page":"23491","DOI":"10.1074\/jbc.M002052200","article-title":"Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue","volume":"275","author":"Aviel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0025","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1021\/jacs.6b10893","article-title":"Structure and dynamics of the Huntingtin Exon-1 N-Terminus: a solution NMR perspective","volume":"139","author":"Baias","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.nbd.2017.10.002_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","article-title":"Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis","volume":"30","author":"Barmada","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1563","article-title":"Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models","volume":"10","author":"Barmada","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2017.10.002_bb0040","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1073\/pnas.1509744112","article-title":"Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1","volume":"112","author":"Barmada","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.10.002_bb0045","doi-asserted-by":"crossref","first-page":"41414","DOI":"10.1074\/jbc.M407201200","article-title":"The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue","volume":"279","author":"Ben-Saadon","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0050","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1073\/pnas.1402215111","article-title":"Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A","volume":"111","author":"Bhat","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.10.002_bb0055","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0060","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1093\/emboj\/17.20.5964","article-title":"A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein","volume":"17","author":"Breitschopf","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2017.10.002_bb0065","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nsmb1295","article-title":"E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages","volume":"14","author":"Christensen","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.nbd.2017.10.002_bb0070","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1128\/MCB.24.14.6140-6150.2004","article-title":"N-terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome","volume":"24","author":"Coulombe","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2017.10.002_bb0075","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1073\/pnas.1204542109","article-title":"Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice","volume":"109","author":"Crook","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.10.002_bb0080","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.10.002_bb0085","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2017.10.002_bb0090","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.10.002_bb0095","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201490361","article-title":"TRIM5\u03b1 requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription","author":"Fletcher","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2017.10.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1507534112","article-title":"Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21","author":"Fletcher","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.10.002_bb0105","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.nbd.2017.10.002_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.10.002_bb0115","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.10.002_bb0120","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0125","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1093\/hmg\/ddr314","article-title":"Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of Huntington disease","volume":"20","author":"Guzhova","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","article-title":"Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach","volume":"13","author":"Hay","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.10.002_bb0135","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","article-title":"Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease","volume":"27","author":"Heng","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0140","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4161\/auto.6.8.13617","article-title":"Early alterations of autophagy in Huntington disease-like mice","volume":"6","author":"Heng","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2017.10.002_bb0145","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/hmg\/ddq285","article-title":"Early autophagic response in a novel knock-in model of Huntington disease","volume":"19","author":"Heng","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.10.002_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.2002.1562","article-title":"Lysine-independent ubiquitination of Epstein-Barr virus LMP2A","volume":"300","author":"Ikeda","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.nbd.2017.10.002_bb0155","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","article-title":"Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition","volume":"19","author":"Kim","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0160","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1101\/gad.1213904","article-title":"N-terminal polyubiquitination and degradation of the Arf tumor suppressor","volume":"18","author":"Kuo","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2017.10.002_bb0165","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2017.10.002_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2010.08.001","article-title":"K63-linked ubiquitination and neurodegeneration","volume":"43","author":"Lim","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.10.002_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.nbd.2017.10.002_bb0180","doi-asserted-by":"crossref","first-page":"13986","DOI":"10.1073\/pnas.0906463106","article-title":"Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin\/proteasome system impairment","volume":"106","author":"Maynard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.10.002_bb0185","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1523\/JNEUROSCI.3001-05.2005","article-title":"CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo","volume":"25","author":"Miller","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0190","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","article-title":"Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into Huntington's disease molecular pathogenesis","volume":"30","author":"Miller","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0195","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1074\/jbc.M111.252577","article-title":"Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein","volume":"287","author":"Nucifora","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","article-title":"PIAS1 regulates mutant huntingtin accumulation and Huntington's disease-associated phenotypes in vivo","volume":"90","author":"Ochaba","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.10.002_bb0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","article-title":"SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation","volume":"4","author":"O'Rourke","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2017.10.002_bb0210","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1523\/JNEUROSCI.5673-09.2010","article-title":"Acute polyglutamine expression in inducible mouse model unravels ubiquitin\/proteasome system impairment and permanent recovery attributable to aggregate formation","volume":"30","author":"Ortega","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0215","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2017.10.002_bb0220","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1038\/sj.onc.1203989","article-title":"Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue","volume":"19","author":"Reinstein","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2017.10.002_bb0225","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","article-title":"Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis","volume":"64","author":"Sapp","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2017.10.002_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2017.10.002_bb0235","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molcel.2011.05.036","article-title":"Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP","volume":"43","author":"Scaglione","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2017.10.002_bb0240","doi-asserted-by":"crossref","first-page":"18784","DOI":"10.1074\/jbc.C113.477596","article-title":"The ubiquitin-conjugating enzyme (E2) ube2w ubiquitinates the N terminus of substrates","volume":"288","author":"Scaglione","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/837015","article-title":"The ubiquitin-proteasome system in huntington's disease: Are proteasomes impaired, initiators of disease, or coming to the rescue?","author":"Schipper-Krom","year":"2012","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.nbd.2017.10.002_bb0250","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.10.002_bb0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of Huntingtin and Huntington's disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.nbd.2017.10.002_bb0260","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddm311","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","volume":"17","author":"Takahashi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.10.002_bb0265","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/BJ20130244","article-title":"Ube2W conjugates ubiquitin to \u03b1-amino groups of protein N-termini","volume":"453","author":"Tatham","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2017.10.002_bb0270","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/hmg\/ddg074","article-title":"Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein","volume":"12","author":"Taylor","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.10.002_bb0275","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2011.05.004","article-title":"Balancing act: deubiquitinating enzymes in the nervous system","volume":"34","author":"Todi","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0280","doi-asserted-by":"crossref","first-page":"32614","DOI":"10.1074\/jbc.M403794200","article-title":"Ubiquitin-proteasome-mediated degradation of Id1 is modulated by MyoD","volume":"279","author":"Trausch-Azar","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0285","doi-asserted-by":"crossref","first-page":"40192","DOI":"10.1074\/jbc.M110.131615","article-title":"Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1{alpha} via the N-terminal pathway","volume":"285","author":"Trausch-Azar","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0290","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2017.10.002_bb0295","article-title":"Intrinsic disorder drives N-terminal ubiquitination by Ube2w","author":"Vittal","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2017.10.002_bb0300","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.2250-09.2009","article-title":"Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease","volume":"29","author":"Wacker","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.10.002_bb0305","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice","volume":"180","author":"Wang","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2017.10.002_bb0310","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1074\/jbc.M115.676601","article-title":"Loss of the ubiquitin-conjugating enzyme UBE2W results in susceptibility to early postnatal lethality and defects in skin, immune, and male reproductive systems","volume":"291","author":"Wang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0315","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2007.05032.x","article-title":"Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease","volume":"104","author":"Weiss","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2017.10.002_bb0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JHD-130058","article-title":"The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease","volume":"2","author":"Zeng","year":"2013","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.nbd.2017.10.002_bb0325","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nbd.2015.06.017","article-title":"Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3","volume":"82","author":"Zeng","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.10.002_bb0330","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","article-title":"Glutamine repeats and neurodegeneration","volume":"23","author":"Zoghbi","year":"2000","journal-title":"Annu. Rev. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611730222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611730222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:11:43Z","timestamp":1760850703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611730222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":66,"alternative-id":["S096999611730222X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.10.002","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}